Zimmer Biomet beats Q4 earnings and revenue estimates, with sales up 10.9% and shares rising 1.4% pre-market despite margin contraction.
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.31 per share a year ago.
Zimmer Biomet on Tuesday beat Wall Street estimates for fourth-quarter profit and revenue as the company capitalized on steady demand for its devices used in orthopedic procedures.
Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basis Fourth quarter diluted earnings per s
Zimmer Biomet Holdings, Inc. (NYSE: ZBH - Get Free Report) has been assigned a consensus rating of "Hold" from the twenty-one research firms that are covering the stock, MarketBeat.com reports. Three
Evaluate the expected performance of Zimmer (ZBH) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics f
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- National shareholder rights law
ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- National shareholder rights
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- National shareholder rights law
Pre-Market Stock Futures: Futures are trading mixed after a solid start to the week, with all the major indices, except the Russell 2000, finishing the day higher. Anticipation of earnings reports fro
SAN FRANCISCO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that cal
Campbell and CO Investment Adviser LLC acquired a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) during the undefined quarter, according to the company in its most recent 13F filin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE